[Dyslipidemia - when are lipid lowering medications useful in clinical practice?]

Blum, Manuel; Stanga, Zeno; Rodondi, Nicolas (2013). [Dyslipidemia - when are lipid lowering medications useful in clinical practice?]. Praxis - schweizerische Rundschau für Medizin, 102(10), pp. 585-589. Huber 10.1024/1661-8157/a001286

Full text not available from this repository.

Dyslipidemia is one of the main modifiable cardiovascular risk factors. There is strong evidence for the efficacy of lipid-lowering drugs in secondary prevention, as well as in primary prevention for patients at high cardiovascular risk. In primary prevention, indication for lipid-lowering interventions should be based on an individual assessment of the cardiovascular risk and on the LDL cholesterol level, despite less strong evidence for the efficacy of drug-based interventions in low risk patients. Treatment consists of statins, as well as lifestyle modifications such as body weight control and increased physical exercise. The latter constitute the primary intervention in patients at low cardiovascular risk. Secondary dyslipidemias due to an underlying medical condition and familial dyslipidemias such as Familial Hypercholesterolemia and Familial Combined Hyperlipidemia should be identified and treated accordingly, taking into account that the risk scoring systems are not appropriate in these situations.

Item Type:	Journal Article (Review Article)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition 04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine 04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
UniBE Contributor:	Blum, Manuel, Stanga, Zeno, Rodondi, Nicolas
Subjects:	600 Technology > 610 Medicine & health
ISSN:	1661-8157
Publisher:	Huber
Language:	English
Submitter:	Patricia Rajaonina
Date Deposited:	01 Apr 2014 08:30
Last Modified:	02 Mar 2023 23:23
Publisher DOI:	10.1024/1661-8157/a001286
PubMed ID:	23644243
URI:	https://boris.unibe.ch/id/eprint/39497